Innovative oral formulations with silicon nanoparticles for co-delivery of poorly soluble drugs and hydrogen gas
using cCVD Si NPs is feasible, though formulation optimization remains an essential task for further development.
Authors
- Jo Klaveness (ORCID: https://orcid.org/0000-0002-4494-3129)
- Werner Filtvedt
- Hennie Marie Johnsen (ORCID: https://orcid.org/0000-0002-8414-0478)
- Marianne Hiorth (ORCID: https://orcid.org/0000-0001-8525-6248)
- Maria Tuyet Nhi Nguyen
- Tove Larsen
Institutions
- University of Oslo (NO)
- Biofokus (NO)
Publication Details
- Journal
- International Journal of Pharmaceutics
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1016/j.ijpharm.2026.126845
- Primary Topic
- Hydrogen's biological and therapeutic effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Norges Forskningsråd